IIQ vs MVP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

IIQ

INOVIQ LTD FPO [IIQ]

56MEDIUM

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

Score Breakdown

IIQ MVP
Technical
58
68
Catalyst
54
50
Sentiment
50
50
Fundamental
91
95
Momentum
39
51
Risk Gate
50
50

Key Metrics

IIQ Metric MVP
$26.7MMarket Cap$52.9M
111KAvg Volume (20d)214K
N/AShort InterestN/A
$0.56552-Week High$0.765
$0.16552-Week Low$0.365
+5.7%Daily Change+2.2%
$0.185Reference Price$0.460
-42.2%ROE+1.1%
N/AProfit Margin+1.5%

Active Signals

IIQ Signals

MACD momentum is picking up steam
Above-average volume (1.8x) on a green day — buyers stepping up
Below the 200-day average — the long-term trend is still working against it
Adequate cash runway (6 quarters)
Moderate P/S ratio (12.1x)
Moderate revenue growth (+11%)
EPS estimates revised upward (+10pts)
Near 52-week low (6% of range)

MVP Signals

Stochastic is deep in oversold territory — bounce conditions forming
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Low P/S ratio (1.2x)
Moderate revenue growth (+10%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare IIQ and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

LDX vs MVP →LGP vs MVP →MVP vs SPL →AHC vs CGS →ARX vs IMM →
IIQ Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).